RxDoctor Payments Data

Craig Dowden, MD

Family Medicine · Fairhope, ALNPI 1568509198

Payments from drug & device makers

$3,153in general payments, 2019–2025

Across 225 payments — averaging $14.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$666
  • Novo Nordisk$633
  • Johnson & Johnson$619
  • GSK$230
  • Abbott$230
  • Pfizer$125
  • plus $651 from 20 others

What the payments were for

  • Food & beverage$3,153100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,153 in reported general payments places this provider in the 75th percentile of 1,680 family medicine providers in Alabama.

See all family medicine providers in Alabama

Medicare billing

Part B allowed, 2024
$146,916
Medicare patients
588
Services billed
7,740

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide134$150,243
EliquisApixaban107$86,931
MounjaroTirzepatide73$81,504
TrulicityDulaglutide54$68,033
JardianceEmpagliflozin54$64,892
FarxigaDapagliflozin Propanediol29$26,732
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$23,469
JanuviaSitagliptin Phosphate18$23,226
Tresiba Flextouch U-200Insulin Degludec18$20,270
XareltoRivaroxaban20$19,396
RybelsusSemaglutide12$18,747
TrintellixVortioxetine Hydrobromide24$15,095
LinzessLinaclotide22$14,462
Janumet XrSitagliptin Phos/Metformin Hcl14$10,907
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen480$10,900

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$633$168,990146 claims
Lilly USA, LLCMounjaro, Trulicity$34$149,537127 claims
PfizerEliquis$125$86,931107 claims
AstraZenecaFarxiga, Breztri Aerosphere$56$35,34043 claims
MerckJanuvia, Janumet Xr$83$34,13332 claims
GSKTrelegy Ellipta$230$23,46927 claims
Johnson & JohnsonXarelto$619$19,39620 claims
AbbVieLinzess, Synthroid$666$17,14060 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$19$15,09524 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,680 family medicine providers in Alabama.

Other family medicine in Fairhope

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →